adesso SE

Informe acción XTRA:ADN1

Capitalización de mercado: €325.5m

adesso Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Mark Lohweber

Chief Executive Officer (CEO)

€612.0k

Compensación total

Porcentaje del salario del CEO52.29%
Permanencia del CEO2.9yrs
Participación del CEOn/a
Permanencia media de la dirección2.9yrs
Promedio de permanencia en la Junta Directiva3.2yrs

Actualizaciones recientes de la dirección

Recent updates

Actualización de narrativa Jun 06

ADN1: Sustained Digitalisation Demand Will Support Earnings Outlook Through 2026

Analysts have reduced their price target for adesso from €95.00 to €65.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. What's in the News adesso reaffirmed earnings guidance for fiscal 2026, citing sustained demand for digitalisation projects, even as the German government now assesses the economy’s 2026 recovery trends as significantly weaker, source: company guidance update.
Actualización de narrativa May 23

ADN1: 2026 Guidance And Dividend Outlook Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €107.67 to about €103.33, pointing to shifts in model assumptions around the discount rate, revenue growth, profit margins and future P/E as the key drivers behind the change. What's in the News adesso SE reaffirmed its earnings guidance for fiscal 2026, citing sustained demand for digitalisation projects despite the German government assessing weaker recovery trends for the German economy in 2026, particularly linked to energy prices (Corporate Guidance).
Actualización de narrativa May 09

ADN1: 2026 Earnings Guidance And Dividend Policy Will Support Future Upside Potential

Analysts have reduced their price target on adesso from €114.17 to €107.67, citing slightly revised revenue growth and P/E assumptions along with a modestly higher profit margin outlook. What's in the News adesso reaffirmed earnings guidance for 2026, with expected revenues in a range of €1.6b to €1.7b and guidance that EBIT margin is expected to show only a little improvement in 2026 (Corporate Guidance).
Actualización de narrativa Apr 24

ADN1: Higher Discount Rate Will Create Long Term Opportunity

Analysts have reduced their price target on adesso from €160 to €140, citing updated assumptions for a higher discount rate, slightly lower revenue growth and profit margin expectations, and a higher future P/E multiple. What's in the News adesso SE reaffirmed earnings guidance for 2026, with expected revenues in a range between €1.6b and €1.7b and only a little improvement in the EBIT margin in that year (Corporate Guidance).
Actualización de narrativa Apr 10

ADN1: Dividend Visibility And Expanded Partnership Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €127.83 to about €114.17. They now apply a higher discount rate, slightly lower revenue growth and profit margin assumptions, and a higher future P/E multiple in their models.
Artículo de análisis Apr 07

Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality

When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...
Artículo de análisis Feb 12

The Price Is Right For adesso SE (ETR:ADN1) Even After Diving 28%

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 28%. Instead...
Artículo de análisis Jan 22

adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Artículo de análisis Oct 19

Is There Now An Opportunity In adesso SE (ETR:ADN1)?

adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...
Artículo de análisis Sep 12

A Piece Of The Puzzle Missing From adesso SE's (ETR:ADN1) 32% Share Price Climb

adesso SE ( ETR:ADN1 ) shareholders would be excited to see that the share price has had a great month, posting a 32...
Artículo de análisis Sep 10

Here's What's Concerning About adesso's (ETR:ADN1) Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Artículo de análisis May 25

Solid Earnings Reflect adesso's (ETR:ADN1) Strength As A Business

adesso SE's ( ETR:ADN1 ) earnings announcement last week was disappointing for investors, despite the decent profit...
Artículo de análisis Feb 25

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.75

The board of adesso SE ( ETR:ADN1 ) has announced that the dividend on 6th of June will be increased to €0.75, which...
User avatar
Nueva narrativa Feb 07

Ongoing IT Investments Will Transform Operations By Mid-2025

Organic growth in healthcare and utilities drives future revenue, overcoming economic challenges, while strategic share buybacks reflect belief in undervaluation.
Artículo de análisis Dec 02

Investors Still Aren't Entirely Convinced By adesso SE's (ETR:ADN1) Revenues Despite 32% Price Jump

adesso SE ( ETR:ADN1 ) shares have continued their recent momentum with a 32% gain in the last month alone. Not all...
Artículo de análisis Nov 22

adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Investors signalled that they were pleased with adesso SE's ( ETR:ADN1 ) most recent earnings report. Looking deeper at...
Artículo de análisis Nov 17

adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...
Artículo de análisis Nov 02

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Artículo de análisis Aug 28

It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 25%. Instead...
Artículo de análisis May 21

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Artículo de análisis Apr 19

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Artículo de análisis Apr 18

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Artículo de análisis Apr 02

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

The market for adesso SE's ( ETR:ADN1 ) shares didn't move much after it posted weak earnings recently. We did some...
Artículo de análisis Mar 28

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Last week saw the newest full-year earnings release from adesso SE ( ETR:ADN1 ), an important milestone in the...
Artículo de análisis Mar 23

Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

Key Insights adesso's estimated fair value is €193 based on 2 Stage Free Cash Flow to Equity Current share price of...
Artículo de análisis Mar 08

adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

adesso SE ( ETR:ADN1 ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Not all...
Artículo de análisis Dec 14

A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €95.16 With €91.00 share price...
Artículo de análisis Oct 11

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Artículo de análisis Jul 22

At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

adesso SE ( ETR:ADN1 ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Artículo de análisis Jun 15

Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €146 With €123 share price...
Artículo de análisis May 09

adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Artículo de análisis Apr 22

What Does adesso SE's (ETR:ADN1) Share Price Indicate?

While adesso SE ( ETR:ADN1 ) might not be the most widely known stock at the moment, it saw significant share price...
Artículo de análisis Feb 11

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Mark Lohweber en comparación con los beneficios de adesso?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2026n/an/a

€27m

Dec 31 2025€612k€320k

€18m

Sep 30 2025n/an/a

€5m

Jun 30 2025n/an/a

€4m

Mar 31 2025n/an/a

-€739k

Dec 31 2024€548k€320k

€3m

Sep 30 2024n/an/a

€5m

Jun 30 2024n/an/a

-€758k

Mar 31 2024n/an/a

-€2m

Dec 31 2023€318k€135k

€3m

Compensación vs. Mercado: La compensación total ($USD701.27K) de Mark está en línea con el promedio de empresas de tamaño similar en el mercado German ($USD1.00M).

Compensación vs. Ingresos: La compensación de Mark ha sido consistente con los resultados de la empresa en el último año.


CEO

Mark Lohweber (57 yo)

2.9yrs
Permanencia
€612,000
Compensación

Mr. Mark Lohweber serves as Head of Line-of-Business Banking at adesso SE and serves as its Member of Executive Board since July 01, 2023. He is familiar with the challenges facing growth-oriented companie...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Volker Gruhn
Co-Founder & Chairperson of the Supervisory Board29.4yrs€58.00k27.92%
€ 90.9m
Mark Lohweber
Chairman of Executive Board & CEO2.9yrs€612.00ksin datos
Rainer Rudolf
Co-Founder & Deputy Chairperson of the Supervisory Board29.4yrs€36.00k16.51%
€ 53.7m
Andreas Prenneis
MD & Member of Executive Board11.2yrs€555.00ksin datos
Kristina Gerwert
Member of Executive Board2.9yrs€489.00ksin datos
Benedikt Bonnmann
Member of the Executive Board2.2yrs€555.00ksin datos
Michael Karl Knopp
Member of Executive Board1.4yrs€545.00ksin datos
Martin Mollmann
Head of Investor Relationsno datasin datossin datos
Peter de Lorenzi
Head of the IT Management Consulting Business Areano datasin datossin datos
2.9yrs
Permanencia media
59yo
Promedio de edad

Equipo directivo experimentado: El equipo directivo de ADN1 se considera experimentado (2.9 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Volker Gruhn
Co-Founder & Chairperson of the Supervisory Board29.4yrs€58.00k27.92%
€ 90.9m
Rainer Rudolf
Co-Founder & Deputy Chairperson of the Supervisory Board12.9yrs€36.00k16.51%
€ 53.7m
Michael Kenfenheuer
Member of Supervisory Board1yr€14.00ksin datos
Christoph Junge
Member of Supervisory Board1yr€18.00ksin datos
Stefanie Kemp
Member of the Supervisory Board3.4yrs€25.00ksin datos
Michael Zorc
Member of Supervisory Board3yrs€25.00ksin datos
3.2yrs
Permanencia media
63.5yo
Promedio de edad

Junta con experiencia: La junta directiva de ADN1 se considera experimentada (3.2 años de antigüedad promedio).


Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/06/19 10:20
Precio de las acciones al final del día2026/06/19 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

adesso SE está cubierta por 11 analistas. 6 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Daniel GroßjohannBankM AG
Wolfgang SpechtBerenberg
Finn KemperHauck Aufhäuser Investment Banking